We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BVS icon
11601
Bioventus
BVS
$1.2B
$226K ﹤0.01%
15,905
-6,880
-30% -$106K
DUSL icon
11602
Direxion Daily Industrials Bull 3X ETF
DUSL
$62.7M
$226K ﹤0.01%
+6,025
New +$262K
FTS icon
11603
PUT
Fortis
FTS
$29B
$226K ﹤0.01%
+5,100
New +$231K
KRO icon
11604
CALL
KRONOS Worldwide
KRO
$975M
$226K ﹤0.01%
18,200
+2,100
+13% +$27.8K
NAUT icon
11605
Nautilus Biotechnolgy
NAUT
$114M
$226K ﹤0.01%
+36,892
New +$294K
NREF
11606
NexPoint Real Estate Finance
NREF
$319M
$226K ﹤0.01%
+11,592
New +$240K
PCYO icon
11607
CALL
Pure Cycle
PCYO
$271M
$226K ﹤0.01%
17,000
-19,200
-53% -$278K
VVOS icon
11608
CALL
Vivos Therapeutics
VVOS
$4.77M
$226K ﹤0.01%
+2,240
New +$235K
PHLT
11609
DELISTED
Performant Healthcare Inc
PHLT
$226K ﹤0.01%
57,103
-46,032
-45% -$203K
ASXC
11610
CALL
DELISTED
Asensus Surgical, Inc.
ASXC
$226K ﹤0.01%
121,900
-199,600
-62% -$448K
MDRX
11611
PUT
DELISTED
Veradigm Inc. Common Stock
MDRX
$226K ﹤0.01%
16,900
-41,900
-71% -$676K
SUNL.WS
11612
DELISTED
Sunlight Financial Holdings, Inc. Warrants, exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SUNL.WS
$226K ﹤0.01%
+207,422
New +$229K
TCRR
11613
CALL
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$226K ﹤0.01%
+26,500
New +$374K
BSJM
11614
DELISTED
Invesco BulletShares 2022 High Yield Corporate Bond ETF
BSJM
$226K ﹤0.01%
9,714
-330,813
-97% -$7.71M
FST
11615
PUT
DELISTED
FAST Acquisition Corp.
FST
$226K ﹤0.01%
17,800
-300
-2% -$3.7K
ATAXZ
11616
PUT
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
$226K ﹤0.01%
38,000
+4,100
+12% +$24.4K
BLKB icon
11617
CALL
Blackbaud
BLKB
$2.05B
$225K ﹤0.01%
3,200
-1,900
-37% -$134K
BZH icon
11618
Beazer Homes USA
BZH
$872M
$225K ﹤0.01%
13,023
-116,777
-90% -$2.09M
CYCN icon
11619
Cyclerion Therapeutics
CYCN
$17.7M
$225K ﹤0.01%
3,669
-846
-19% -$55.4K
GOSS icon
11620
CALL
Gossamer Bio
GOSS
$75.4M
$225K ﹤0.01%
17,900
-2,700
-13% -$24.9K
HOPE icon
11621
PUT
Hope Bancorp
HOPE
$1.85B
$225K ﹤0.01%
+15,600
New +$213K
LXRX icon
11622
Lexicon Pharmaceuticals
LXRX
$1.03B
$225K ﹤0.01%
46,856
+35,223
+303% +$145K
TG icon
11623
Tredegar Corp
TG
$276M
$225K ﹤0.01%
18,491
-2,128
-10% -$27.3K
AVGR
11624
DELISTED
Avinger, Inc. Common Stock
AVGR
$225K ﹤0.01%
1,008
+896
+800% +$247K
MTBL
11625
CALL
DELISTED
Moatable, Inc. American Depositary Share (each representing forty-five (45) Class A Ordinary Shares)
MTBL
$225K ﹤0.01%
162,000
+46,000
+40% +$51.2K

Similar funds

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.